Emerald Health Therapeutics, Inc.

CVE: EMH


Canadian symbol: EMH.V
US symbol: EMHTF

Currency in CAD

Valuation Measures

Market Cap (intraday) 541.03M
Enterprise Value 369.53M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.95
Price/Book (mrq)0.35
Enterprise Value/Revenue 33.30
Enterprise Value/EBITDA 6-1.64

Trading Information

Stock Price History

Beta (5Y Monthly) 0.83
52-Week Change 3-90.28%
S&P500 52-Week Change 314.65%
52 Week High 32.6500
52 Week Low 30.1200
50-Day Moving Average 30.1941
200-Day Moving Average 30.2105

Share Statistics

Avg Vol (3 month) 3912.68k
Avg Vol (10 day) 3508.38k
Shares Outstanding 5200.14M
Float 159.98M
% Held by Insiders 121.06%
% Held by Institutions 14.54%
Shares Short (Jul. 14, 2020) 4243.73k
Short Ratio (Jul. 14, 2020) 40.36
Short % of Float (Jul. 14, 2020) 4N/A
Short % of Shares Outstanding (Jul. 14, 2020) 40.12%
Shares Short (prior month Jun. 14, 2020) 4395.48k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Sep. 08, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-226.59%

Management Effectiveness

Return on Assets (ttm)-15.05%
Return on Equity (ttm)-80.96%

Income Statement

Revenue (ttm)21.08M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)35.60%
Gross Profit (ttm)-10.79M
EBITDA -42.44M
Net Income Avi to Common (ttm)-112.43M
Diluted EPS (ttm)-0.7220
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)581k
Total Cash Per Share (mrq)0
Total Debt (mrq)29M
Total Debt/Equity (mrq)27.51
Current Ratio (mrq)0.59
Book Value Per Share (mrq)0.58

Cash Flow Statement

Operating Cash Flow (ttm)-19.06M
Levered Free Cash Flow (ttm)-52.27M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
EMH.V
Emerald Health Therapeutics
4 days ago
EMH.V
Emerald Health Therapeutics
4 days ago
EMH.V
Emerald Health Therapeutics
1 month ago
EMH.V
Emerald Health Therapeutics
2 months ago
EMH.V
Emerald Health Therapeutics
2 months ago
EMH.V
Emerald Health Therapeutics
2 months ago
EMH.V
Emerald Health Therapeutics
4 months ago
EMH.V
Emerald Health Therapeutics
4 months ago
EMH.V
Emerald Health Therapeutics
4 months ago
EMH.V
Emerald Health Therapeutics
4 months ago
EMH.V
Emerald Health Therapeutics
4 months ago
EMH.V
Emerald Health Therapeutics
5 months ago
EMH.V
Emerald Health Therapeutics
5 months ago
EMH.V
Emerald Health Therapeutics
5 months ago
EMH.V
Emerald Health Therapeutics
6 months ago
EMH.V
Emerald Health Therapeutics
6 months ago
EMH.V
Emerald Health Therapeutics
7 months ago
EMH.V
Emerald Health Therapeutics
7 months ago
EMH.V
Emerald Health Therapeutics
7 months ago
EMH.V
Emerald Health Therapeutics
7 months ago
EMH.V
Emerald Health Therapeutics
7 months ago
EMH.V
Emerald Health Therapeutics
7 months ago
EMH.V
Emerald Health Therapeutics
7 months ago
EMH.V
Emerald Health Therapeutics
7 months ago
EMH.V
Emerald Health Therapeutics
7 months ago
EMH.V
Emerald Health Therapeutics
7 months ago
EMH.V
Emerald Health Therapeutics
7 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
9 months ago
EMH.V
Emerald Health Therapeutics
9 months ago
EMH.V
Emerald Health Therapeutics
9 months ago
EMH.V
Emerald Health Therapeutics
9 months ago
EMH.V
Emerald Health Therapeutics
9 months ago
EMH.V
Emerald Health Therapeutics
9 months ago
EMH.V
Emerald Health Therapeutics
9 months ago
EMH.V
Emerald Health Therapeutics
9 months ago
EMH.V
Emerald Health Therapeutics
10 months ago
EMH.V
Emerald Health Therapeutics
10 months ago
EMH.V
Emerald Health Therapeutics
10 months ago
EMH.V
Emerald Health Therapeutics
11 months ago
EMH.V
Emerald Health Therapeutics
11 months ago
EMH.V
Emerald Health Therapeutics
11 months ago
EMH.V
Emerald Health Therapeutics
11 months ago
EMH.V
Emerald Health Therapeutics
11 months ago
EMH.V
Emerald Health Therapeutics
11 months ago
EMH.V
Emerald Health Therapeutics
11 months ago
EMH.V
Emerald Health Therapeutics
11 months ago
EMH.V
Emerald Health Therapeutics
11 months ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago

Currency in CAD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPSN/A-0.11N/AN/A
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts1011
Avg. Estimate4.27MN/A20.32M52.3M
Low Estimate11MN/A27.9M52.3M
High Estimate11MN/A27.9M52.3M
Year Ago Sales970kN/A1.95M20.32M
Sales Growth (year/est)340.40%N/A943.10%157.40%
Earnings HistoryInvalid Date2018-12-302019-06-292019-09-29
EPS Est.N/A0-0.06-0.05
EPS ActualN/A-0.110-0.12
DifferenceN/A-0.110.06-0.07
Surprise %N/AN/A100.00%-140.00%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate0000
7 Days Ago-0.050-0.2-0.21
30 Days Ago-0.050-0.2-0.21
60 Days Ago-0.050-0.2-0.21
90 Days Ago-0.050-0.2-0.21
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesEMH.VIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current YearN/AN/AN/AN/A
Next YearN/AN/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
21.06%% of Shares Held by All Insider
4.54%% of Shares Held by Institutions
5.75%% of Float Held by Institutions
7Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
AdvisorShares Investments, LLC1,355,210Jun. 29, 20200.72%230,385

Top Mutual Fund Holders

HolderSharesDate Reported% OutValue
ETF Managers Tr-EFTMG Alternative Harvest ETF3,216,006Mar. 30, 20201.70%659,281
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF1,256,559Mar. 30, 20200.67%257,594
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Emerald Health Therapeutics, Inc.


Emerald Health Therapeutics Announces Stock Option Grant

Emerald Health Therapeutics Announces Stock Option Grant

Vancouver, British Columbia--(Newsfile Corp. - August 3, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") announces that it has issued an aggregate of 3,800,000 stock options to employees, consultants and directors at an exercise price of $0.21 per common share for a period of five years. All stock options ... Read More...
Emerald Health Therapeutics and Quinto Resources Enter into Share Purchase Agreement for Sale of Quebec Cannabis Business

Emerald Health Therapeutics and Quinto Resources Enter into Share Purchase Agreement for Sale of Quebec Cannabis Business

Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) ("Emerald") and Quinto Resources Inc. ("Quinto") (TSXV: QIT) today announced that they have entered into a share purchase agreement dated July 30, 2020 (the "Agreement") in respect of the sale of Emerald's wholly-owned subsidiarie... Read More...
Emerald Health Therapeutics' Pure Sunfarms Joint Venture Begins Shipping Branded Products to Manitoba

Emerald Health Therapeutics’ Pure Sunfarms Joint Venture Begins Shipping Branded Products to Manitoba

Pure Sunfarms remains top-selling dried cannabis brand with Ontario Cannabis Store1 and achieves sales records in JulyVANCOUVER, July 24, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has beg... Read More...
Emerald Health Therapeutics Terminates Consulting and Loan Agreements

Emerald Health Therapeutics Terminates Consulting and Loan Agreements

VANCOUVER, July 15, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has terminated certain related party agreements pertaining to consulting services and a loan facility.Emerald Health Sciences Inc. ("EHS"), a control person of Emerald, and Emerald entered into an independent contractor agreement on May 1, ... Read More...
Emerald Health Therapeutics Announces Completion of Accordion Provision of Pure Sunfarms' Credit Facility

Emerald Health Therapeutics Announces Completion of Accordion Provision of Pure Sunfarms’ Credit Facility

VANCOUVER, British Columbia, July 01, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has further expanded its credit facility (the “Credit Facility”) with the lending syndicate led by Bank of ... Read More...
Emerald Health Therapeutics' Joint Venture Pure Sunfarms' Branded Products Ship to Saskatchewan and are Approved in Manitoba

Emerald Health Therapeutics’ Joint Venture Pure Sunfarms’ Branded Products Ship to Saskatchewan and are Approved in Manitoba

VANCOUVER, British Columbia, June 24, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has begun shipping branded, packaged dried flower products to Saskatchewan following approval from the Sask... Read More...
Emerald Health Therapeutics' Verdélite Launches Souvenir™ Cannabis Brand in Québec

Emerald Health Therapeutics’ VerdĂ©lite Launches Souvenir™ Cannabis Brand in QuĂ©bec

VANCOUVER, British Columbia, June 23, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that its Verdélite Sciences subsidiary in St. Eustache, Québec, has launched its new Souvenir cannabis brand in the province. The Souvenir product line initially consists of select dried flower products from two ... Read More...
Emerald Health Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

Emerald Health Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, June 19, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and ended March 31, 2020. Full versions of the Company’s unaudited condensed interim consolidated financial statements and MD&A can be found on SEDAR at www.sedar.com.“In the ... Read More...
Emerald Health Therapeutics to Host 2020 First Quarter Financial Results Conference Call on Friday, June 19, 2020 at 10:30 AM ET

Emerald Health Therapeutics to Host 2020 First Quarter Financial Results Conference Call on Friday, June 19, 2020 at 10:30 AM ET

VANCOUVER, British Columbia, June 11, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that, further to its news release on April 29th, Emerald will report its financial results for the first quarter ended March 31, 2020, after the market close on Thursday, June 18, 2020. The company will hos... Read More...
Emerald Health Therapeutics Closes $2.1 Million Prospectus Sale

Emerald Health Therapeutics Closes $2.1 Million Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, June 02, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), is pleased to announce that it has closed its prospectus offering (the "Offering") to certain institutional accredited investors (the... Read More...
Emerald Health Therapeutics Terminates Land Sub-lease and Outdoor Cultivation Agreements

Emerald Health Therapeutics Terminates Land Sub-lease and Outdoor Cultivation Agreements

VANCOUVER, British Columbia, May 27, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that it has terminated certain related party agreements pertaining to its cannabis cultivation operation in Metro Vancouver. Previously existing rights and continuing usage of the land and its cultivation operatio... Read More...
Emerald Health Therapeutics Announces Pure Sunfarms' Initial Cultivation and Sales License for Second Greenhouse

Emerald Health Therapeutics Announces Pure Sunfarms’ Initial Cultivation and Sales License for Second Greenhouse

VANCOUVER, British Columbia, May 25, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received from Health Canada its cannabis cultivation and sales licence based on an initial production area wit... Read More...
Emerald Announces $2.1 Million Prospectus Sale

Emerald Announces $2.1 Million Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, May 21, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), has entered into a binding term sheet with a single Canadian institutional accredited investor (the “Investor”) under which the Invest... Read More...
Emerald Health Therapeutics Reports Pure Sunfarms First Quarter 2020 Financial Results

Emerald Health Therapeutics Reports Pure Sunfarms First Quarter 2020 Financial Results

Pure Sunfarms achieves fifth consecutive profitable quarter and 179% quarter-to-quarter growth in retail branded product sales volume; builds on retail success in Ontario with 20% market share in April; continues leadership in low-cost cultivationVANCOUVER, British Columbia, May 15, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (T... Read More...
Emerald Health Therapeutics Reports Year-end and Fourth Quarter 2019 Financial Results and Provides Corporate Update

Emerald Health Therapeutics Reports Year-end and Fourth Quarter 2019 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, May 14, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and year ended December 31, 2019. Full versions of the Company’s audited consolidated financial statements and MD&A can be found on SEDAR at www.sedar.com.“In the second half o... Read More...
Emerald Health Therapeutics to Host 2019 Fourth Quarter and Year End Financial Results Conference Call on Thursday, May 14, 2020 at 10:30 AM ET

Emerald Health Therapeutics to Host 2019 Fourth Quarter and Year End Financial Results Conference Call on Thursday, May 14, 2020 at 10:30 AM ET

VANCOUVER, May 08, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that, further to its news release on April 29th, Emerald will report audited financial results for the fourth quarter and year ended December 31, 2019 after the market close on Wednesday, May 13, 2020. The company will host a... Read More...
Emerald Health Therapeutics Extends Dates for Filing Financial Statements

Emerald Health Therapeutics Extends Dates for Filing Financial Statements

VANCOUVER, April 29, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that as a result of the COVID-19 pandemic, Emerald, as well as its auditors and filing agents, have followed the recommendations of local health authorities and temporarily closed their offices, having employees work remotely to ... Read More...
Emerald Health Therapeutics to Launch Rapid Onset Nanoemulsion Cannabinoid & Terpene Product Line, Providing Consumers with Enhanced Immediacy and Control

Emerald Health Therapeutics to Launch Rapid Onset Nanoemulsion Cannabinoid & Terpene Product Line, Providing Consumers with Enhanced Immediacy and Control

Unique product line uses advanced technology to improve cannabinoid absorption by roughly 65% to provide more predictable dosing, onset and effects, as well as discreetness and value, of THC and CBD products for medicinal and adult-use usersVANCOUVER, April 29, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF... Read More...
Emerald Health Therapeutics Proposes to Amend Warrant Terms

Emerald Health Therapeutics Proposes to Amend Warrant Terms

VANCOUVER, British Columbia, April 06, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that it intends to amend the terms of certain common share purchase warrants originally issued on September 9, 2019 (the “Warrants”).An aggregate of 12,500,000 Warrants were initially issued at an exercise price... Read More...
Emerald Health Therapeutics Releases First Harvest of Premium Cannabis from its 100%-Owned Cultivation Facility in Richmond, BC

Emerald Health Therapeutics Releases First Harvest of Premium Cannabis from its 100%-Owned Cultivation Facility in Richmond, BC

Purpose-built facility for organic cannabis production adds to Emerald’s ability to grow and sell its own unique premium-quality cannabis productsTwo wholly-owned operations in full production position Emerald for financial growth and sustainabilityVANCOUVER, British Columbia, April 06, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”... Read More...
Emerald Health Therapeutics' Pure Sunfarms JV Expands Credit Facility with Existing Lender by up to $59M and Completes Additional $8M Financing

Emerald Health Therapeutics’ Pure Sunfarms JV Expands Credit Facility with Existing Lender by up to $59M and Completes Additional $8M Financing

VANCOUVER, British Columbia, April 03, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced that its Pure Sunfarms (“PSF”) joint venture has finalized the expansion of its credit facility with its existing lender to $59 million, including accordion provisions of $22.5 million. The expanded credit facil... Read More...
Emerald Health Therapeutics' Pure Sunfarms JV Expands Credit Facility with Existing Lender by up to $59M

Emerald Health Therapeutics’ Pure Sunfarms JV Expands Credit Facility with Existing Lender by up to $59M

VANCOUVER, BC / ACCESSWIRE / March 31, 2020 / Emerald Health Therapeutics, Inc. ("Emerald") (TSXV:EMH; OTCQX:EMHTF) announced that its Pure Sunfarms ("PSF") joint venture has expanded its credit facility with its existing lender to $59 million, including accordion provisions of $22.5 million. The expanded credit facility (the "Credit Faci... Read More...
Emerald Health Therapeutics' Joint Venture, Pure Sunfarms, Reports Positive Operating and Financial Growth in 2019, with Significant EBITDA Performance of $54.1 Million

Emerald Health Therapeutics’ Joint Venture, Pure Sunfarms, Reports Positive Operating and Financial Growth in 2019, with Significant EBITDA Performance of $54.1 Million

VANCOUVER, BC / ACCESSWIRE / March 31, 2020 / Emerald Health Therapeutics, Inc. ("Emerald") (TSXV:EMH; OTCQX:EMHTF) has provided audited financial results for the fourth quarter and year of 2019 for its British Columbia-based joint venture, Pure Sunfarms (PSF).Financial DataAll comparable figures are for the year and quarter ended Decembe... Read More...
Emerald Health Therapeutics' Pure Sunfarms JV Receives Health Canada Approval for State-of-the-Art Processing Centre

Emerald Health Therapeutics’ Pure Sunfarms JV Receives Health Canada Approval for State-of-the-Art Processing Centre

Expanded processing facility enables further optimization of operations and quality processes Pure Sunfarms also increases market share in Ontario in first months of 2020 and launches new larger-format packageVANCOUVER, BC / ACCESSWIRE / March 23, 2020 / Emerald Health Therapeutics, Inc. ("Emerald") (EMH.V)(EMHTF) announced that its Pure ... Read More...
Emerald Health Therapeutics Signs LOI with Sigma Analytical Services

Emerald Health Therapeutics Signs LOI with Sigma Analytical Services

VANCOUVER, British Columbia, March 09, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) (“Emerald”) has signed a letter of intent under which Sigma Analytical Services Inc. (“Sigma”), a full-service GMP-compliant testing laboratory for cannabis, hemp, and derived products, may acquire Emerald’s Avalite canna... Read More...
Emerald Health Therapeutics, Pure Sunfarms, and Village Farms Complete Settlement of All Disputes

Emerald Health Therapeutics, Pure Sunfarms, and Village Farms Complete Settlement of All Disputes

VANCOUVER, British Columbia, March 09, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that, further to its news release dated March 3, 2020, all transactions contemplated by the settlement agreement (the "Settlement Agreement") among Emerald, Village Farms International, Inc. ("Village Farm... Read More...
Emerald Health Therapeutics, Pure Sunfarms, and Village Farms Settle All Disputes

Emerald Health Therapeutics, Pure Sunfarms, and Village Farms Settle All Disputes

VANCOUVER, British Columbia, March 03, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has entered into a settlement agreement (the "Settlement Agreement") with Village Farms International, Inc. ("Village Farms") and Pure Sunfarms Corp. ("PSF," and together with Emerald and Village Farms, the "Parties") reg... Read More...
Emerald Health Therapeutics' Pure Sunfarms Joint Venture Makes First Cannabis Shipment to Alberta

Emerald Health Therapeutics’ Pure Sunfarms Joint Venture Makes First Cannabis Shipment to Alberta

VANCOUVER, British Columbia, Feb. 26, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced that its 50%-owned joint venture for large-scale, low-cost, quality cannabis production, Pure Sunfarms Corp. (“Pure Sunfarms” or “PSF”), has completed its first shipment of cannabis under its supply agreement wit... Read More...
Emerald Health Therapeutics Closes Final Tranche Prospectus Sale

Emerald Health Therapeutics Closes Final Tranche Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Feb. 14, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has closed the final tranche of its $3,000,000 prospectus offering (the “Offering”), announced in its news release dated January 6, 20... Read More...
Emerald Health Therapeutics Closes $2.2 Million Prospectus Sale

Emerald Health Therapeutics Closes $2.2 Million Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Feb. 06, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has closed the first tranche of its $3,000,000 prospectus offering (the “Offering”) announced in its news release dated January 6, 202... Read More...
Emerald Health Therapeutics Closes Shares for Debt Financing

Emerald Health Therapeutics Closes Shares for Debt Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Jan. 31, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), is pleased to announce that it has closed its previously announced shares for debt financing. Further to its news release dated Janua... Read More...
Emerald Health Therapeutics Provides Update on Financing Transactions

Emerald Health Therapeutics Provides Update on Financing Transactions

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Jan. 27, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today provided an update on a previously announced shares for debt transaction. Further to its news release dated December 16, 2019, E... Read More...
Emerald Health Therapeutics' Joint Venture Partner Withdraws Purported $5.94 Million Investment in Pure Sunfarms

Emerald Health Therapeutics’ Joint Venture Partner Withdraws Purported $5.94 Million Investment in Pure Sunfarms

VANCOUVER, British Columbia, Jan. 17, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that Village Farms International, Inc. ("Village Farms") has withdrawn its attempt to make an unsupported  additional equity contribution in their joint venture, Pure Sun Farms Corp. (“PSF”). Village Farms ... Read More...
Emerald Health Therapeutics Announces Second Tranche of $4.5 Million Financing

Emerald Health Therapeutics Announces Second Tranche of $4.5 Million Financing

VANCOUVER, British Columbia, Jan. 06, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), has entered into a binding term sheet with certain institutional accredited investors (the “Investors”) under which the Investors have agreed, subject to certain customary conditions, to purchase 10,344,827 units of Emera... Read More...
Emerald Health Therapeutics Closes Initial Tranche of Private Placement

Emerald Health Therapeutics Closes Initial Tranche of Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Dec. 30, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), announced today that it has closed the initial tranche of a private placement which was announced on December 16, 2019. Private Place... Read More...
Emerald Health Therapeutics Enters into Multi-Year Extraction and White Label Service Agreement with Valens

Emerald Health Therapeutics Enters into Multi-Year Extraction and White Label Service Agreement with Valens

VANCOUVER, British Columbia, Dec. 23, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has entered into a multi-year agreement (the "Agreement") with Valens GroWorks Corp. (“Valens” or “The Valens Company”) (TSXV: VLNS; OTCQX: VLNCF) to contract cannabis extraction and white-label product development service... Read More...
Emerald Health Therapeutics Announces Financing Transactions

Emerald Health Therapeutics Announces Financing Transactions

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Dec. 16, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced today that it is carrying out a financing and entering into a shares for debt transaction. Private Placement Emerald intends... Read More...
Emerald Health Therapeutics Reports Third Quarter 2019 Financial Results; Sales Double Third Quarter in a Row

Emerald Health Therapeutics Reports Third Quarter 2019 Financial Results; Sales Double Third Quarter in a Row

50% owned JV, Pure Sunfarms, achieves fourth consecutive quarter of positive EBITDA, all-in cost of production of C$0.63 per gram, gross margin of 69% and EBITDA margin of 73%VANCOUVER, British Columbia, Dec. 02, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and ... Read More...
Emerald Health Therapeutics Closes $2.5 Million Prospectus Sale and Concurrent Secondary Sale

Emerald Health Therapeutics Closes $2.5 Million Prospectus Sale and Concurrent Secondary Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Nov. 29, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), announced today that it closed its prospectus sale (the "Offering") to a single Canadian institutional accredited investor (the “Inve... Read More...
Emerald Health Therapeutics Maintains 50% Share Ownership in Pure Sunfarms

Emerald Health Therapeutics Maintains 50% Share Ownership in Pure Sunfarms

VANCOUVER, British Columbia, Nov. 27, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today responded to misleading public disclosure made by Village Farms International, Inc. ("Village Farms") (TSX: VFF; Nasdaq: VFF) yesterday in connection with their joint venture, Pure Sunfarms Corp. ("PSF").Emerald reit... Read More...
Emerald Health Therapeutics’ Pure Sunfarms Joint Venture to Supply Cannabis Products to Alberta

Emerald Health Therapeutics’ Pure Sunfarms Joint Venture to Supply Cannabis Products to Alberta

VANCOUVER, British Columbia, Nov. 27, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced that its 50%-owned joint venture for large-scale, low-cost, quality cannabis production, Pure Sunfarms Corp. (“Pure Sunfarms” or “PSF”), has secured a cannabis supply agreement with Alberta Gaming, Liquor & C... Read More...
Emerald Health Therapeutics Completing Planting in Recently Fully-Licensed, Wholly-Owned Growing Facilities

Emerald Health Therapeutics Completing Planting in Recently Fully-Licensed, Wholly-Owned Growing Facilities

VANCOUVER, British Columbia, Nov. 26, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has completed planting at its indoor Québec facility, Verdélite, and expects to complete planting in the next days in the first of its two greenhouses in Metro Vancouver, allowing for transition into the commercial phase o... Read More...
Emerald Health Therapeutics Responds to Inaccurate Allegations by Village Farms

Emerald Health Therapeutics Responds to Inaccurate Allegations by Village Farms

VANCOUVER, British Columbia, Nov. 20, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today responded to inaccurate allegations made by Village Farms International, Inc. ("Village Farms") (TSX: VFF; Nasdaq: VFF) in connection with their 50/50 joint venture, Pure Sunfarms Corp. ("PSF"), and updated the marke... Read More...
Meta Growth Extends Maturity Date of $9m Loan to December 31, 2022

Meta Growth Extends Maturity Date of $9m Loan to December 31, 2022

TORONTO , Nov. 19, 2019 - National Access Cannabis Corp (META.V) d/b/a Meta Growth ("Meta Growth", "META" or "the Company"), Canada's largest publicly traded recreational cannabis retailer by revenue1, is pleased to announce that it has reached a new agreement to extend its $9,000,000 loan (the "Loan") from Opaskwayak Cree Nation ("OCN") ... Read More...
Emerald Health Therapeutics' Pure Sunfarms JV Records Q3 Net Sales of $24.0 Million, 69% Gross Margin, 56% EBITDA Margin, Fourth Consecutive Quarter of Positive EBITDA, and $0.63/gram All-in Production Cost

Emerald Health Therapeutics’ Pure Sunfarms JV Records Q3 Net Sales of $24.0 Million, 69% Gross Margin, 56% EBITDA Margin, Fourth Consecutive Quarter of Positive EBITDA, and $0.63/gram All-in Production Cost

Pure Sunfarms is #1 dried flower brand with Ontario Cannabis Store in October, with 16% market share and #1 selling productEmerald to report third quarter 2019 financial results on November 29th and hold conference call December 2ndVANCOUVER, British Columbia, Nov. 15, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQ... Read More...
Emerald Health Therapeutics Announces $2.5 Million Prospectus Sale and Concurrent Secondary Sale

Emerald Health Therapeutics Announces $2.5 Million Prospectus Sale and Concurrent Secondary Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Nov. 13, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), has entered into a binding term sheet with a single Canadian institutional accredited investor (the “Investor”) under which the Inves... Read More...
Emerald Health Therapeutics Receives Organic Certification for Greenhouse and Outdoor Metro Vancouver Operation

Emerald Health Therapeutics Receives Organic Certification for Greenhouse and Outdoor Metro Vancouver Operation

VANCOUVER, British Columbia, Nov. 12, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has received organic certification for cannabis production at its Metro Vancouver operation in British Columbia, which encompasses 156,000 square feet in two greenhouses as well as 12 acres (~500,000 square feet) of licens... Read More...
Emerald Health Therapeutics to Supply STENOCARE with Medical Cannabis Products for Denmark

Emerald Health Therapeutics to Supply STENOCARE with Medical Cannabis Products for Denmark

VANCOUVER, British Columbia, Nov. 07, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has signed an agreement to become a new supplier to STENOCARE A/S (“STENOCARE”) of medical cannabis for Denmark and STENOCARE’s international markets.Since early September 2019, Emerald and STENOCARE have worked closely to... Read More...
Emerald Health Therapeutics Announces Internal Reorganization

Emerald Health Therapeutics Announces Internal Reorganization

Reorganization will cut costs and focus on improving cash flow and differentiated competitive positioningVANCOUVER, British Columbia, Oct. 30, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has announced an internal reorganization including the reduction of its workforce and other expenditures. It is at th... Read More...
Coming Soon.

Delayed data (1h)


Share this page